Cite
HARVARD Citation
Ding, Y. et al. (2018). Transverse myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high‐risk neuroblastoma: A case series. Pediatric blood & cancer. 65 (1), p. n/a. [Online].